6501 - 6510 of 7939 Results
Title
Year
- Neural substrates of excessive daytime sleepiness in early drug naïve Parkinson's disease: A resting state functional MRI study2016RESTRICTEDTitle: Neural substrates of excessive daytime sleepiness in early drug naïve Parkinson's disease: A resting state functional MRI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 24Issue #:Start Page: 63End Page: 68Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.01.012Citation Count: 41
- Synthesis of a Bis-thio-acetone (BTA) Analogue of the Lysine Isopeptide Bond and its Application to Investigate the Effects of Ubiquitination and SUMOylation on α-Synuclein Aggregation and Toxicity2016OPENTitle: Synthesis of a Bis-thio-acetone (BTA) Analogue of the Lysine Isopeptide Bond and its Application to Investigate the Effects of Ubiquitination and SUMOylation on α-Synuclein Aggregation and ToxicityJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 11Issue #: 4Start Page: 931End Page: 942Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.5b01042Best OA location URL: https://europepmc.org/articles/pmc6300141?pdf=renderCitation Count: 30
- Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats2016RESTRICTEDTitle: Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian ratsJournal Name: Pharmacology Biochemistry and BehaviorPublisher: Elsevier BVVol: 142Issue #:Start Page: 64End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pbb.2016.01.004Citation Count: 21
- Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease2016RESTRICTEDTitle: Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2015.00500Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2015.00500/pdfCitation Count: 127
- Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia2016OPENTitle: Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesiaJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 115Issue #: 3Start Page: 1713End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00868.2015Best OA location URL: https://europepmc.org/articles/pmc4809970Citation Count: 22
- Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases2016RESTRICTEDTitle: Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative DiseasesJournal Name: Annual Review of Pharmacology and ToxicologyPublisher: Annual ReviewsVol: 56Issue #: 1Start Page: 489End Page: 510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1146/annurev-pharmtox-010715-103548Best OA location URL: https://www.annualreviews.org/doi/pdf/10.1146/annurev-pharmtox-010715-103548Citation Count: 72
- LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate2016OPENTitle: LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rateJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0066-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-015-0066-zCitation Count: 159
- Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease2016RESTRICTEDTitle: Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson DiseaseJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 88Issue #: 3Start Page: 1856End Page: 1863Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.analchem.5b04227Citation Count: 75
-
RESTRICTEDTitle: Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2016Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/7351985Best OA location URL: http://downloads.hindawi.com/journals/pd/2016/7351985.pdfCitation Count: 24
-
RESTRICTEDTitle: Autosomal dominant Parkinson's disease caused by SNCA duplicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S1End Page: S6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.007Best OA location URL: https://europepmc.org/articles/pmc4820832?pdf=renderCitation Count: 151